BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 22, 2020
View Archived Issues
OCT1 overexpression tied to poor prognosis in DLBCL
Read More
Singapore HSA approves CANbridge's IND for CAN-106 for complement dysregulation diseases
Read More
CTA approved in Belgium for phase l/lla study of oncolytic virus BT-001 in solid tumors
Read More
BI-767551 enters phase I/IIa development
Read More
ImmuneMed progresses hzVSF-v13 into phase II clinical development in various countries
Read More
Initiation of phase I study evaluating MB-101 in patients with leptomeningeal brain tumors
Read More
Fintepla approved in Europe for the treatment of seizures in Dravet syndrome
Read More
Enanta Pharmaceuticals divulges compounds for HBV infection
Read More
Sage Therapeutics has patented GABA(A) receptor modulators
Read More
Pfizer/BioNTech COVID-19 vaccine receives conditional marketing authorization in Europe
Read More
Celgene synthesizes new CKI-alpha degradation inducers
Read More
Aligos Therapeutics presents HBV and HDV antivirals
Read More
City of Hope National Medical Center divulges new CARs for treating T-cell lymphoma
Read More
EC grants approval for Libmeldy gene therapy as treatment of early-onset MLD
Read More
Phase III HOPE-B study of etranacogene dezaparvovec meets first coprimary endpoint
Read More
Endothelial stress products in circulating blood as biomarkers for COVID-19
Read More
Stem cell-derived vesicles protective against neonatal hemorrhage
Read More
Menin/KMT2A inhibitor KO-539 shows encouraging preliminary results for treating R/R AML
Read More
HX-008 plus chemotherapy demonstrates promising safety and efficacy in first-line mTNBC
Read More
BioCryst reports encouraging phase I data on BCX-9250 for fibrodysplasia ossificans progressiva
Read More
BioEclipse initiates first-in-human study of CRX-100 to treat refractory solid tumors
Read More
Sellas reports initial data on galinpepimut-S with checkpoint inhibitors for ovarian cancer and MPM
Read More
Annexon begins phase II/III study of ANX-005 for Guillain-Barre syndrome
Read More
CureVac opens phase III study of COVID-19 vaccine CVnCoV in healthcare workers
Read More
DTRM-555 meets primary endpoint in first-in-human study with patients with B-cell lymphomas
Read More
OSE initiates phase II trial of OSE-127 in ulcerative colitis
Read More
European Commission approves cabotegravir and rilpivirine long-acting injectable for HIV
Read More
Polyphor cleared to begin phase I study of inhaled murepavadin
Read More
Topline ACCOLADE data for avacopan in C3 glomerulopathy
Read More
Phase II study of AZR-MD-001 for contact lens discomfort meets primary endpoints
Read More